Seroprevalence of bactericidal antibody against Neisseria meningitidis serogroup C in pre-vaccinal era: The Italian epidemiological scenario

Vaccine

Volumn 27, Issue 25-26, 2009, Pages 3435-3438

  Gasparini, R ^a   Rizzetto, R ^a   Sasso, T ^a   Rizzitelli, E ^a   Manfredi, P ^b   Risso, D ^a   Gentile, C ^c   Atti, M Ciofi degli ^d,e   Panatto, D ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^e ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Neissseria meningitidis; Sero epidemiology; Vaccine

Indexed keywords

BACTERIUM ANTIBODY; MENINGOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODY BLOOD LEVEL; ARTICLE; BACTERICIDAL ACTIVITY; BLOOD SAMPLING; CHILD; HUMAN; HUMAN TISSUE; INFANT; ITALY; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROEPIDEMIOLOGY; SEROPREVALENCE;

ADOLESCENT; ADULT; AGE FACTORS; ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; ITALY; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS, SEROGROUP C; SEROEPIDEMIOLOGIC STUDIES; VACCINATION;

EID: 67349249790     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.01.076     Document Type: Article

References (20)

1. CDC-ACIP. Prevention and control of meningococcal disease. MMWR 54 (2005) 1-21
2. European Union Invasive Bacterial Infections Surveillance Network (EU-IBIS). Invasive Neisseria meningitidis in Europe (2006), Health Protection Agency, London. http://www.euibis.org/documents/2006_meningo.pdf [http://www.euibis.org/documents/2006_meningo.pdf, accessed on October 13, 2008]
3. Gold R., Lepow M.L., Goldschneider I., Draper T.F., and Gotschlich E.C. Antibody responses of human infants to three doses of group A Neisseria meningitidis polysaccharide vaccine administered at two, four, and six months of age. J Infect Dis 138 (1978) 731-735
4. Robbins J.B., Myerowitz L., Whisnant J.K., Argaman M., Schneerson R., Handzel Z.T., et al. Enteric bacteria cross-reactive with Neisseria meningitidis groups A and C and Diplococcus pneumoniae types I and 3. Infect Immun 6 (1972) 651-656
5. Greenwood B.M., Greenwood A.M., Bradley A.K., Williams K., Hassan-King M., Shenton F.C., et al. Factors influencing susceptibility to meningococcal disease during an epidemic in The Gambia, West Africa. J Infect 14 (1987) 167-184
6. Santos G.F., Deck R.R., Donnelly J., Blackwelder W., and Granoff D.M. Importance of complement source in measuring meningococcal bactericidal titres. Clin Diagn Lab Immunol 8 (2001) 616-623
7. Trotter C., Borrow R., Andrews N., and Miller E. Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era. Vaccine 21 (2003) 1094-1098
8. Miller E., Salisbury D., and Ramsay M. Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story. Vaccine 20 Suppl 1 (2001) S58-S67
9. Stroffolini T. Vaccination campaign against meningococcal disease in army recruits in Italy. Epidemiol Infect 105 (1990) 579-583
10. Italian Ministry of Health: National Vaccination Plan-2005-07. Supplemento Ordinario della Gazzetta Ufficiale del 14 aprile 2005.
11. D'Ancona F., Alfonsi V., Caporali M., Ranghiasci A., Ciofi degli Atti M.L., and on behalf of the regional referents for infectious diseases and vaccinations. Pneumococcal conjugate, meningococcal C and varicella vaccination in Italy. Eurosurveillance 12 (2007) 25-28
12. Maslanka S.E., Gheesling L.L., Libutti D.E., Donaldson K.B., Harakeh H.S., Dykes J.K., et al. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group. Clin Diagn Lab Immunol 4 (1997) 156-167
13. Borrow R., Andrews N., Goldblatt D., and Miller E. Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection. Infect Immun 69 (2001) 1568-1573
14. SIMI: Dati della sorveglianza sulle malattie batteriche invasive. WEB site: http://www.simi.iss.it/dati.htm#Neisse_BC, accessed on September 6, 2008.
15. EDUFAMILY: Allarme meningite nel milanese: prevenire con il vaccino. WEB site: http://www.edufamily.it/get_object.php?obj_id=2356, accessed on October 13, 2008.
16. Bonanni P., Bechini S., Boccalini S., Pecori L., Graziani G., Balocchini E.C., et al. Vaccination campaign following an increasing number of reported meningitis cases in Tuscany. Vacc Immuniz 1 (2006) 3
17. Ferro A., Baldo V., Cinquetti S., Corziali P., Gallo G., Lustro G., et al. Outbreak of serogroup C meningococcal disease in Veneto region. Italy. Euro Surveill 13 (2008) [pii: 8008]
18. Goldschneider I., Gotschlich E.C., and Artenstein M.S. Human immunity to the meningococcus. I. The role of humoral antibodies. II. Development of natural immunity. J Exp Med 129 (1969) 1307-1348
19. Mitchell L.A., Ochnio J.J., Glover C., Lee A.Y., Ho M.K., and Bell A. Analysis of meningococcal serogroup C-specific antibody levels in British Columbian children and adolescents. J Infect Dis 173 (1996) 1009-1013
20. Imrey P.B., Jackson L.A., Ludwinski P.H., England A.C. III, Fella G.A., Fox B.C., et al. Outbreak of serogroup C meningococcal disease associated with campus bar patronage. Am J Epidemiol 143 (1996) 624-630